MedPath

North China Pharmaceutical Group Corporation

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (100.0%)

Efficacy and Safety Study of Shenwu Capsule

Phase 3
Completed
Conditions
Mild Cognitive Impairment
Interventions
Drug: Shenwu Capsule
First Posted Date
2011-10-14
Last Posted Date
2014-10-10
Lead Sponsor
North China Pharmaceutical Group Corporation
Target Recruit Count
324
Registration Number
NCT01451749
Locations
🇨🇳

Dongzhimen Hospital,BUCM, Beijing, China

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.